Normalisation is medical misogyny and delays diagnosis
Sharnelle Vella, ABC Radio Melbourne breakfast co-host[/caption]
Mike Stephens, Director, Medicines policy and Programs at the National Aboriginal Community Controlled Health Organisation (NACCHO)[/caption]
Chastina Heck MPS, Chair of the PSA/NACCHO Aboriginal and Torres Strait Islander Pharmacy Practice Community of Specialty Interest (CSI).[/caption]
Philippa Chigeza, pharmacist at Logan Hospital.[/caption]
Stewart Mearns MPS[/caption]
The effectiveness of probiotics for the treatment of eczema
Eczema affects up to 20% of children. Almost half of these patients develop eczema by the age of six months and most of them...
COVID-19: Finish line or first lap?
As Australia reaches vaccine targets, what’s next for pharmacists and Australians?
Vale Prof Gabrielle Cooper OAM (1962 to 2025)
PSA is saddened to learn of the passing of Professor Gabrielle Cooper OAM, who died on 23 April after a short illness.
Academic and hospital pharmacist Jacinta Johnson MPS
Growing up in the country, Jacinta Johnson MPS always wanted to work in a healthcare role, and pharmacy seemed to offer opportunities that no...
Aged care innovator is PSA’s 2021 ECP of the Year
Just 3 years out of university, Maria Berbecaru MPS made history by implementing an Australian-first aged care pharmacy service. She hopes her experience will inspire others and help make embedding pharmacists in aged care the norm.
High-dose antipsychotic therapy: does it have a role?
A high proportion of people prescribed antipsychotic polypharmacy are also taking high-dose antipsychotic therapy.
